FindTrial
Sign In

Prognostic value of 18F-FDG PET/CT radiomic model based on primary tumor in patients with non-small cell lung cancer: A large single-center cohort study

Prognostic value of 18F-FDG PET/CT radiomic model based on primary tumor in patients with non-small cell lung cancer: A large single-center cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200062555
Enrollment
Unknown
Registered
2022-08-11
Start date
2022-08-08
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer

Interventions

Gold Standard:hematological test
Index test:18F-FDG PET/CT

Sponsors

The First Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 86 Years

Inclusion criteria

Inclusion criteria: 1. Patients who underwent biopsy or surgery of lung tumor; 2. Patients with IHC examination of PD-L1 performed; 3. Histological type and grade were pathologically proven; 4. Standard 18F-FDG PET/CT was performed before biopsy or surgery; 5. Complete clinical profile.

Exclusion criteria

Exclusion criteria: 1. Therapy (radiotherapy, chemotherapy, or chemoradiotherapy) was performed before 18F-FDG PET/CT and IHC; 2. Patients with unknown histological grade; 3. The size of the primary lesion was too small for segmentation; 4. Multi-center primary lung cancer; 5. Patients with other types of cancers or with incomplete clinical and imaging datasets.

Design outcomes

Primary

MeasureTime frame
Progression-free survival;—

Countries

China

Contacts

Public ContactShengming Deng
dshming@163.com+86 15051510189

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026